# Structure Therapeutics Inc. American Depositary Shares (GPCR)

> Structure Therapeutics Inc. American Depositary Shares (GPCR) trades at $16.13 (-5.78%) as of 7:30:06 PM EST on Nov 20, 2026, -26.45% over the past month. Market cap is $1.15B, with 6.5 days to cover in short interest.

Canonical: https://massive.com/quote/gpcr
Data as of: 2026-11-21T00:30:06.116Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$16.13** -0.99 (-5.78%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$16.69** +0.56 (+3.47%)
As of 7:30:06 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Structure Therapeutics Inc. American Depositary Shares (GPCR) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -5.78% |
| 1W | -19.35% |
| 1M | -26.45% |
| YTD | -76.81% |
| 1Y | -54.31% |
| 52-wk range | $16.06 – $94.90 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for GPCR: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $16.06 – $17.08 |
| Open | $16.73 |
| Prev close | $17.12 |
| Volume | 786.24K |
| Market cap | $1.15B |
| Shares out | 70.03M |

## Valuation and profitability ratios

Valuation and profitability ratios for Structure Therapeutics Inc. American Depositary Shares: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | — |
| P/B | 0.95 |
| P/FCF | — |
| ROE | -24.1% |
| ROA | -22.0% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[Structure Therapeutics Inc. American Depositary Shares (GPCR) insider trading](https://massive.com/quote/gpcr/insider-trading.md): open-market Form 4 buys and sells by Structure Therapeutics Inc. American Depositary Shares insiders over the last 12 months.

## 8-K filings

Material corporate events Structure Therapeutics Inc. American Depositary Shares has disclosed to the SEC on Form 8-K.

- Nov 9, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 9, 2026, Structure Therapeutics Inc. (the "Company") issued a press release providing a corporate update and announcing its financial results for the third quarter ended September 30, 2026.”
- Sep 8, 2026 · [Clinical trial results](https://massive.com/quote/sec-filings/8-k/clinical-trial-results.md)
  “Aleniglipron's safety and tolerability profile remained consistent through 72 weeks. Treatment discontinuations due to TEAEs occurred in fewer than 5% of participants in the OLE.”
- Jun 18, 2026 · Annual meeting results
  “On June 17, 2026, Structure Therapeutics Inc. held its 2026 Annual General Meeting of Shareholders. Ted W. Love M.D., Raymond Stevens, Ph.D. and Daniel G. Welch were elected as a Class III directors with voting results showing 164,241,780 votes for Ted W. Love, 164,373,741 votes for Raymond Stevens, and 161,336,058 votes for Daniel G. Welch.”
- May 7, 2026 · Underwriting agreement
  “On May 7, 2026, Structure Therapeutics Inc. (the "Company") amended and restated that certain Sales Agreement dated August 6, 2025 (the "Sales Agreement" and as amended and restated, the "Amended and Restated Sales Agreement") with Leerink Partners LLC and Cantor Fitzgerald & Co. (collectively, the "Sales Agents"), relating to the offer and sale of the Company's American Depositary Shares ("ADSs").”
- Apr 15, 2026 · Executive compensation change
  “Pursuant to the terms of Mr. Lang's employment agreement, effective as of April 15, 2026, Mr. Lang will receive a base salary of $560,000 per year and be eligible for an annual discretionary bonus with a target amount of 40% of his base salary. Mr. Lang will be granted (i) an option to purchase 223,776 ordinary shares (representing 74,592 American Depositary Shares ("ADSs")), (ii) a time-based restricted share unit award (the "RSUs") in respect of 184,614 ordinary shares (representing 61,538 ADSs) and (iii) a performance-based restricted share unit award (the "PSUs") in respect of 46,155 ordinary shares (representing 15,385 ADSs) at target levels.”

## GPCR short interest

How heavily GPCR is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 6.5 |
| Short interest | 5.93M |
| Avg volume | 911.82K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## GPCR news

The latest news and headlines about Structure Therapeutics Inc. American Depositary Shares (GPCR).

- [Will Wegovy Pill Drive Renewed GLP-1 Growth Momentum for Novo Stock?](https://www.zacks.com/stock/news/3027783/will-wegovy-pill-drive-renewed-glp-1-growth-momentum-for-novo-stock?cid=CS-ZC-FT-analyst_blog|quick_take-3027783) · Zacks Investment Research · Nov 11, 2026 · positive sentiment
- [Novo Up 4% in a Month: How Should Investors Approach the Stock Now?](https://www.zacks.com/stock/news/3026175/novo-up-4-in-a-month-how-should-investors-approach-the-stock-now?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-3026175) · Zacks Investment Research · Nov 9, 2026 · neutral sentiment
- [Novo Before Q3 Earnings: How Should Investors Play the Stock?](https://www.zacks.com/stock/news/3020334/novo-before-q3-earnings-how-should-investors-play-the-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-3020334) · Zacks Investment Research · Nov 2, 2026 · negative sentiment
- [How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?](https://www.zacks.com/stock/news/3012002/how-will-novo-s-glp-1-portfolio-sales-aid-upcoming-q3-results?cid=CS-ZC-FT-analyst_blog|quick_take-3012002) · Zacks Investment Research · Oct 21, 2026 · neutral sentiment
- [How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?](https://www.zacks.com/stock/news/3010617/how-will-eli-lilly-s-glp-1-portfolio-sales-aid-upcoming-q3-results?cid=CS-ZC-FT-analyst_blog|quick_take-3010617) · Zacks Investment Research · Oct 19, 2026 · positive sentiment

## About Structure Therapeutics Inc. American Depositary Shares

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | ADRC |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 281 |
| Listed | Feb 3, 2023 |

[Company website](https://www.structuretx.com)

## FAQ

### What is the Structure Therapeutics Inc. American Depositary Shares (GPCR) stock price today?

Structure Therapeutics Inc. American Depositary Shares (GPCR) is trading at $16.13 (-5.78% on the day) as of 7:30:06 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Structure Therapeutics Inc. American Depositary Shares?

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs.

### What is the short interest in GPCR?

As of Oct 30, 2026, GPCR has 5.93M shares short and 6.5 days to cover.

### What exchange is GPCR listed on?

Structure Therapeutics Inc. American Depositary Shares (GPCR) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time GPCR quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=GPCR`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Structure Therapeutics Inc. American Depositary Shares (GPCR) insider trading](https://massive.com/quote/gpcr/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
